Vivos Therapeutics, Inc.
Customers
0
None disclosed
Suppliers
1
1 disclosed
Latest period
Dec 31, 2025
10-K filed 2026-04-15
Suppliers 1
Companies that disclose VVOS as a major customer, as a share of their own revenue. 1 active, 0 lapsed.
| Company | % of their revenue | Est. $ from VVOS | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Avondale Capital, LLC Non-SEC Avondale Capital, LLC |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-04-15 |
On December 5, 2025, we entered into a Note Purchase Agreement (the “Avondale Note Purchase Agreement”) with from Avondale Capital, LLC, a Utah limited liability company (“Avondale”), pursuant to which the Company issued and sold to Avondale a Promissory Note (the “Avondale Note”) in the original principal amount of $2,093,340 (the financing as described herein, the “Avondale Note Financing”). | ||||||
Alerts are coming
Get an email when VVOS's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.